The study aimed to compare the strut coverage patterns of everolimus-eluting stents (EES) and first-generation drug-eluting stents (DES) using optical coherence tomography (OCT) after more than 12 months of implantation.
The analysis included 66 stents from 40 patients, revealing that EES had significantly better tissue coverage and lower rates of uncovered and malapposed struts compared to first-generation DES.
The findings suggest that EES demonstrate superior late strut coverage patterns, which might contribute to better clinical outcomes than first-generation DES.